Eli Lilly's Path to the Next Trillion Market Capitalization
Eli Lilly and Company TodayLLYEli Lilly and Company516.57▼956.88Add to WatchlistEli Lilly and Co. NYSE: LLY is a pharmaceutical giant that's made headlines for its GLP-1/GIP weight loss drug Tirzepatide, known as Mounjaro for type 2 diabetes, and Zepbound for obesity. Its stock is trading back near its all-time high at 857 billion mark. The company has many growth ...